IC-125 Corneal Fibrosis: Pathophysiology and Farmacological Control with Topical Losartan | ASCRS
Session
IC-125 Corneal Fibrosis: Pathophysiology and Farmacological Control with Topical Losartan
April 2025
Meeting: 2025 ASCRS Annual Meeting
Course Instructor: Lycia Maria P. Sampaio, MD
Co-Instructors: Steven E. Wilson, MD, ABO; Barbara Dutra, MD, MS; Marcony R. Santhiago, MD, PhD; Valeria Villabona Martinez, MD
This content is only available to 2025 ASCRS Annual Meeting physician registrants

To log in, click the teal "Login" button in the upper right-hand corner of this page. If you are logged in but still do not have access, please check your 2025 Annual Meeting registration.

Course Description
Course will help the audience to understand the haze formation (corneal wound healing pathophysiology) and risk factors, discuss the rationale behind the use of topical losartan and the two phase mecanism. Course will also provide a practical clinical guidance how to use topical losartan (indications and posology) and discuss clinical cases of corneal fibrosis treated with topical losartan and potential new applications for the drug.

Educational Objective
Understand haze formation and indications and how to use topical losartan
2025 ASCRS Annual Meeting Instructional Courses

This 1.5 hour Instructional Course was recorded at the 2025 ASCRS Annual Meeting in Los Angeles, CA, April 25-28, 2025.